Researchers analyzed 18 studies where participants learned their risk of diseases that could be lowered by behavioral changes, such as smoking cessation, diet, alcohol use and physical activity.
They found communicating this DNA-based risk to participants was not effective in changing individuals’ health-related behavior.
“Existing evidence does not support expectations that such interventions could play a major role in motivating behavior change to improve population health,” the researchers concluded.
More articles on personalized medicine:
Precision medicine market set to reach $88B by 2022: 4 things to know
What advances in genomic research mean for federal health IT
6 vendors opening data access for Precision Medicine Initiative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
